KENILWORTH, N.J.--(BUSINESS WIRE)--With adverse drug events (ADEs) triggering an estimated 700,000 ED visits and 120,000 hospitalizations, RDx BioScience (RDx) points ...

Prostate cancer (PC) is a significant health concern, being the second leading cause of death among American men. The standard treatment for advanced PC often involves androgen deprivation therapy ...

Expert Rev Mol Diagn. 2012;12(8):841-855. From their experience with PGx testing, the authors believe that this clinical utility in primary care is possible. For instance, the authors recently ...

STONY BROOK, NY / ACCESSWIRE / June 13, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that the New York ...

Have you ever wondered why certain medications don’t seem to work as well for you as they do for others? This variability in drug response is what pharmacogenomic testing hopes to explain by looking ...

Prostate cancer (PC) is a significant health concern, being the second leading cause of death among American men. The standard treatment for advanced PC often involves androgen deprivation therapy ...

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind ®, a leading mental health care company, is launching on August 10, 2019 Genomind Professional PGx Express™, a new, more focused report and set of ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

STONY BROOK, NY / ACCESSWIRE / June 18, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a global leader in PCR-based DNA technologies, today announced that its molecular diagnostics ...

With the rapid advances in the field of genetics and growing understanding of the human brain and body, the past few decades have seen a rise in precision (or personalized) medicine. We know that ...